Moderna, Inc. (MRNA) Financials
MRNA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 11.0 billion | 4.2 billion |
| March 31, 2026 | 11.5 billion | 4.1 billion |
| Dec. 31, 2025 | 12.3 billion | 3.7 billion |
| Sept. 30, 2025 | 12.1 billion | 2.8 billion |
MRNA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -563.0 million | 120.0 million |
| March 31, 2026 | -692.0 million | 104.0 million |
| Dec. 31, 2025 | 912.0 million | 113.0 million |
| Sept. 30, 2025 | -880.0 million | 125.0 million |
MRNA Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| June 30, 2026 | -782.0 million |
| March 31, 2026 | -1.3 billion |
| Dec. 31, 2025 | -826.0 million |
| Sept. 30, 2025 | -200.0 million |
MRNA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 5.1 billion | 591.0 million | 644.0 million |
| March 31, 2026 | 5.2 billion | 590.0 million | 658.0 million |
| Dec. 31, 2025 | 5.8 billion | 1.2 billion | 673.0 million |
| Sept. 30, 2025 | 4.5 billion | 660.0 million | 686.0 million |
MRNA Shares Outstanding
MRNA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 37.0 million | 651.0 million | 216.0 million | - |
| March 31, 2026 | 62.0 million | 649.0 million | 173.0 million | - |
| Dec. 31, 2025 | 39.0 million | 775.0 million | 308.0 million | - |
| Sept. 30, 2025 | 33.0 million | 801.0 million | 268.0 million | - |
MRNA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 145.0 million | 93.0 million |
| March 31, 2026 | 389.0 million | 955.0 million |
| Dec. 31, 2025 | 678.0 million | 452.0 million |
| Sept. 30, 2025 | 1.0 billion | 1.0 billion |
MRNA Revenue by Segment
Graph available only for paid members. Upgrade to see it.
MRNA
Price: $146.69
52 week price:
Payout Ratio Range:
Earnings Per Share: -7.98 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 3.3 million
Market Capitalization: 57.8 billion